Laxmi Organic details $8 million centre scale-up range

Laxmi Organic Industries Ltd. has detailed a $8 million Innovation Centre in Mahape, Navi Mumbai, which spans about 30,000 sq ft and can take complex chemical projects from gram-scale laboratory synthesis to pilot batches of up to 1,800 litres. Inaugurated in February 2025, the centre combines laboratory, kilo-lab and pilot equipment with more than 105 research and engineering personnel.

What does Laxmi Organic's Mahape Innovation Centre include?

Laxmi Organic's Mahape Innovation Centre includes laboratory, kilo-lab and pilot facilities designed for development and process engineering work. The site was inaugurated in February 2025, covers about 30,000 sq ft and involved an investment of $8 million, according to the presentation.

The centre is a larger addition to Laxmi Organic's earlier Mahad Site 1 research setup, which has operated since 2012. Mahad Site 1 has 2,500 sq ft of space and six fume hoods, compared with approximately 30,000 sq ft and 30 fume hoods at Mahape. On those disclosed measures, Mahape has about 12 times the floor area and five times the number of fume hoods.

Laxmi Organic reports more than 65 research and development chemists and scientists, alongside more than 40 engineers and scientists. The presentation separates research and development from process engineering, indicating a stated structure for moving chemistry from molecular work into larger-scale operating conditions. The disclosed groups together comprise more than 105 personnel.

How does Laxmi Organic move chemistry from lab to pilot scale?

Laxmi Organic uses a three-stage path from gram-scale laboratory synthesis to a 20 to 25 litre kilo lab and then a 100 to 1,800 litre pilot facility. The maximum stated pilot volume is 72 times the upper end of the kilo-lab range, showing the scale increase available before commercial manufacturing.

The laboratory has 30 fume hoods as well as analytical and characterisation equipment for complex chemistry and molecule handling. Its specified role is gram-scale synthesis, while the presentation does not give a batch-volume range, pressure range or temperature range for laboratory work.

The kilo lab uses distillation kettles, high-pressure autoclaves and jacketed reactors. Laxmi Organic lists amination, nitration, fluorination, photochlorination and distillation among its kilo-lab processes, with a stated pressure range of 0.3 to 10 bar and temperatures from minus 20°C to 250°C.

The pilot facility extends the equipment and operating envelope beyond the kilo lab. It includes MSGL, Hastelloy, stainless-steel and Inconel reactors, plus bunker facilities and closed rooms, for chlorination, continuous fluorination, ethoxylation and distillation. Pilot operations can run at up to 100 bar and from minus 20°C to 250°C, compared with the kilo lab's 10-bar ceiling at the same temperature range.

Which chemical platforms connect to Laxmi Organic's scale-up work?

Laxmi Organic connects the centre's work to several chemistry platforms, including fluorination, chlorination, nitration and ethoxylation. These processes appear in the kilo lab or pilot descriptions and also overlap with technology platforms identified for the company's Specialties business.

The Specialties business identifies ketene or diketene and fluorination or perfluorination as its main platforms, while also listing ethoxylation, chlorination and nitration on a commercial scale. The Innovation Centre's pilot processes include continuous fluorination, chlorination and ethoxylation, linking development equipment to those stated Specialties capabilities.

At commercial scale, Laxmi Organic lists more than 30 diketene derivatives as well as ethoxylation, cyanation and mercaptans. That commercial list is narrower than the combined laboratory and pilot process list, because the presentation labels the two sets separately. It nevertheless shows that the development platform sits alongside existing commercial process areas rather than being described only as exploratory research.

What customer development work has Laxmi Organic disclosed?

Laxmi Organic has disclosed three customer-development examples: route innovation for a global pharmaceutical company, commercial-scale development of an ethylene oxide derivative for a global innovator, and mercaptan chemistry scale-up for a leading agro-innovator. The presentation identifies the customer categories and chemistry outcomes but does not name customers or disclose project revenue.

For the global pharmaceutical company, Laxmi Organic says it innovated a synthesis route for a key starting raw material to enhance end-product purity. The presentation does not identify the raw material, finished product, production volume or assignment duration, so the disclosed example supports the technical objective but not an assessment of its commercial value.

For a global innovator, Laxmi Organic says it developed an ethylene oxide derivative from laboratory gram scale to commercial scale. This example follows the lab-to-commercial progression outlined through the centre's gram-scale, 20 to 25 litre kilo-lab and 100 to 1,800 litre pilot stages, although the presentation does not specify the project's pilot-batch volume.

The third example states that Laxmi Organic absorbed and scaled up mercaptan chemistry for a leading agro-innovator. Mercaptans are also included in the company's commercial-capability list, while the Specialties business serves pharma, agro-chemicals, dyes and pigments, paints and coatings, flavours and fragrances, flame retardants, electronics and thermal fluids.

How does Mahape change Laxmi Organic's development infrastructure?

Mahape changes Laxmi Organic's disclosed development infrastructure by adding dedicated kilo-lab and pilot capability to a research base that previously included the 2,500 sq ft Mahad Site 1 laboratory. The newer Mahape site has 30 fume hoods versus six at Mahad Site 1 and was inaugurated 13 years after Mahad began operating in 2012.

The equipment change is as material as the space increase. Mahad Site 1 is described through its 2,500 sq ft footprint and six fume hoods, whereas Mahape adds high-pressure autoclaves, jacketed reactors, corrosion-resistant pilot reactors, closed rooms and a bunker facility. Mahape's pilot capability reaches 1,800 litres and 100 bar, neither of which is disclosed for Mahad Site 1.

Laxmi Organic does not disclose the number of active programmes at Mahape, annual development expenditure, commercialisation rates or centre-specific sales. It also does not quantify how many of its more than 30 commercial diketene derivatives, ethoxylation products, cyanation products or mercaptans originated through the new centre.

Conclusion

Laxmi Organic has set out a defined research-to-scale-up framework at its $8 million Mahape centre: gram-scale synthesis in the laboratory, 20 to 25 litre kilo-lab work and pilot runs of up to 1,800 litres. The facility's 30,000 sq ft footprint, 30 fume hoods and more than 105 disclosed research and engineering personnel provide the stated infrastructure behind customer work in pharmaceutical, ethylene oxide derivative and mercaptan chemistry.

The next disclosures to watch are details that the presentation leaves unresolved, including project counts, customer identities, commercial launch timing and sales contribution. Laxmi Organic has identified commercial areas including more than 30 diketene derivatives, ethoxylation, cyanation and mercaptans, but has not assigned a revenue target or timetable to projects emerging from the Mahape platform.